More stories

  • in

    Trump Administration Ends Program Critical to Search for an H.I.V. Vaccine

    The termination is the latest in a series of cuts to H.I.V. research and programs to prevent the disease.The Trump administration has dealt a sharp blow to work on H.I.V. vaccines, terminating a $258 million program whose work was instrumental to the search for a vaccine.Officials from the H.I.V. division of the National Institutes of Health delivered the news on Friday to the program’s two leaders, at Duke University and the Scripps Research Institute.Both teams were collaborating with numerous other research partners. The work was broadly applicable to a wide range of treatments for other illnesses, from Covid drugs to snake antivenom and therapies for autoimmune diseases.“The consortia for H.I.V./AIDS vaccine development and immunology was reviewed by N.I.H. leadership, which does not support it moving forward,” said a senior official at the agency who was not authorized to speak on the matter and asked not to be identified.“N.I.H. expects to be shifting its focus toward using currently available approaches to eliminate H.I.V./AIDS,” the official said.The program’s elimination is the latest in a series of cuts to H.I.V.-related initiatives, and to prevention of the disease in particular. Separately, the N.I.H. also paused funding for a clinical trial of an H.I.V. vaccine made by Moderna.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions

    The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.The Food and Drug Administration on Friday approved the Novavax Covid-19 vaccine, but only for older adults and for others over age 12 who have at least one medical condition that puts them at high risk from Covid.Scientific advisers to the Centers for Disease Control and Prevention, who typically make decisions on who should get approved shots and when, have been debating whether to recommend Covid shots only to the most vulnerable Americans. The F.D.A.’s decision appeared to render at least part of their discussion moot.The new restriction will sharply limit access to the Novavax vaccine for people under 65 who are in good health. It may leave Americans who do not have underlying conditions at risk if a more virulent version of the coronavirus were to emerge. It could also limit options for people who want the vaccine for a wide array of reasons, including to protect a vulnerable loved one.The vaccine had previously been authorized under emergency use. Covid vaccines developed by Pfizer-BioNTech and Moderna, which are more widely used by Americans, were granted full approval in 2022. However, the companies are working on updated shots for the fall, and the new restrictions on the Novavax shot portend a more restrictive approach from the F.D.A.The F.D.A.’s new restrictions also appeared to reflect the high degree of skepticism about vaccines from Robert F. Kennedy Jr., the health secretary, and the other leaders he has appointed at health agencies.“This is incredibly disappointing,” said Dr. Camille Kotton, an infectious disease physician at Massachusetts General Hospital who cares for immunocompromised patients, and a former adviser to the C.D.C.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    F.D.A. Approves First At-Home Alternative to the Pap Smear

    The tool will allow women to screen for HPV, which causes almost all cases of cervical cancer, without visiting a doctor.The Food and Drug Administration approved the United States’ first at-home cervical cancer screening tool on Friday, a decision that stands to give women an accessible alternative to Pap smears, which many find painful or traumatic.The new test, made by Teal Health, involves swabbing the vagina with a spongelike tool rather than inserting a speculum and scraping cells from the cervix, as doctors do in Pap smears.Similar vaginal tests were approved last year for use in medical offices. But the at-home version could help women who have trouble finding, traveling to or making time for an in-person appointment.The approval is a result of a process that began with the discovery decades ago that the human papillomavirus, commonly known as HPV, causes almost all cervical cancer cases, and that people who don’t have the virus are at virtually no risk.Armed with that information, many doctors started testing Pap smear samples for HPV in addition to analyzing cervical cells under a microscope. Some medical authorities shifted to recommend HPV testing as the primary screening method, which opened the door for vaginal tests, because the virus can be detected in vaginal as well as cervical cells.Cervical cancer experts told The New York Times that the evidence for at-home testing was strong, and studies show it to be about as accurate as Pap smears.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Flu Killed 25 Children in New York This Season, the Most in Many Years

    Amid declining vaccination rates, the 2024-25 influenza season exacted a heavy toll, with 216 pediatric deaths nationwide.Amid dropping vaccination rates, 25 children in New York State died from influenza during the 2024-25 flu season — more than in any recent flu season, state health authorities said on Wednesday.The Centers for Disease Control and Prevention has estimated that more than 47 million people nationwide caught the flu between fall and spring and that more than 600,000 have been hospitalized. The hospitalization rate for flu is the highest it has been in 15 years.A number of factors have probably contributed to influenza’s heavy toll. Since the Covid-19 pandemic, more people have chosen not to be vaccinated against the seasonal flu. And some researchers believe that the mix of strains circulating this year tend to be associated with more intense flu seasons.The C.D.C. has attributed 216 pediatric deaths nationwide to the flu this season, a number that is expected to climb before the end of the season, which is receding. More than 10 percent of those deaths occurred in New York State, which is home to less than 6 percent of the nation’s children.Of the 25 children who died from flu, only one was vaccinated, the state health commissioner, Dr. James V. McDonald, noted. Five were too young to be vaccinated, he said in a statement. The flu vaccine is not approved for children younger than 6 months.The decline in flu vaccinations reflects a rising tide of distrust of the scientific establishment, which has left many people questioning the safety or effectiveness of vaccines. Before the pandemic, the share of Americans who received an annual flu shot had been slowly climbing.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    5 Places to Turn for Accurate Health Information

    Changes to federal health websites have raised concerns about their reliability. These independent sources offer an alternative.Soon after President Donald J. Trump took office for his second term, thousands of health websites run by the federal government that kept the public informed about infectious diseases, mental health, vaccines and more were taken offline.Many eventually returned — in large part because a judge ordered the Centers for Disease Control and Prevention to temporarily restore the pages — but some had been altered, with sections on topics such as health equity and teen pregnancy deleted. The changes, along with uncertainty around the future of these sites, has led some public health experts to question whether the websites can still be trusted as the gold standard of trustworthy health information, as they’ve long been regarded.Federal health agencies are already facing a crisis of confidence. When a recent national poll asked respondents how much trust they had in the C.D.C. to make the right health recommendations, more than one-third replied “not much” or “not at all.” Nearly half said the same about the Food and Drug Administration.Experts fear that with less trust in public health institutions, more people seeking medical information might turn to social media, where misinformation is rampant. That has made it all the more valuable for the public to find evidenced-based sources of health information.Here are five websites run by independent organizations that have accurate, easy-to-understand information.1. Vaccine Education CenterOf all the health information on federal websites, medical experts have been increasingly concerned about the availability of accurate vaccine information. Robert F. Kennedy Jr., the nation’s health secretary, has been a longtime critic of vaccines and has spread misinformation about their safety for years.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    ‘A Veneer of Official Medical Knowledge’: Three Opinion Writers on Kennedy’s Tenure

    Alexandra Sifferlin, a health and science editor for Times Opinion, hosted a written conversation with the Opinion columnist Ross Douthat and the Opinion writers Jessica Grose and David Wallace-Wells about Robert F. Kennedy Jr.’s first two months as secretary of health and human services.Alexandra Sifferlin: Robert F. Kennedy Jr. vowed to tackle chronic disease and take on the food and pharmaceutical industries. But his response to a measles outbreak in the Southwest — and inflammatory remarks about autism at a press briefing — have drawn criticism from all sides.Ross, you’ve written about your own experiences with chronic illness and the limitations of the U.S. medical system. What’s been your view of Kennedy’s Make America Healthy Again movement, and what do you make of his tenure as health leader so far?Ross Douthat: I think debates about the limitations of the U.S. medical system tend to be polarized in a very, shall we say, unhealthy way. On one side, you have people who haven’t hit the limits of medical consensus and knowledge in their own lives, and therefore struggle to understand why so many of their fellow citizens would want to wander outside those limits in search of answers or wisdom. On the other side, you have people with very good reasons for skepticism of conventional wisdom, but who have allowed that skepticism to become total, making them reject everything the establishment says while fastening onto a specific outsider narrative as an absolute alternative even if the evidence is lacking.On a lot of fronts, Kennedy and the MAHA movement exhibit the latter problem. There’s absolutely room for new research and new debate about the causes of chronic illness, or autism or obesity — all areas where the official understanding of things doesn’t have definite answers for a lot of people. And there’s always good reason for skepticism about the medical-industrial complex writ large. But Kennedy seems committed to his own set of low-evidence theories — the vaccine-autism link being the most prominent example — and he seems to be working backward from the outsider perspective, rather than trying to genuinely create dialogue between the establishment and its critics.David Wallace-Wells: I’m not sure it’s even just low-evidence theories. I worry about the quality of the evidence demonstrating the problem. One thing I’d really like to see an autism commission tackle is the seemingly simple question of to what degree we actually are really living through an epidemic. I think there are reasons to worry about an increase in cases, and about environmental factors contributing. But I also think the alarming charts you see showing exponential growth in prevalence are really not very credible, and yet they are what is powering our panic.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    How Much Vaccination Stops a Measles Outbreak?

    <!–> [!–> <!–> –><!–> [–><!–> –><!–> [–><!–>Just how many? To let you discover for yourself, we simulated an outbreak of a hypothetical disease, about as contagious as the flu. (A lot less contagious than measles.)–><!–> –><!–> [–><!–>We’d like you to contain it. But first, some basics:–><!–> –><!–> [!–> <!–> –><!–>Here’s a sick person in a […] More

  • in

    Experts Doubt Kennedy’s Timetable for Finding the Cause of Autism

    The nation’s health secretary announced that he planned to invite scientists to provide answers by September, but specialists consider that target date unrealistic.Robert F. Kennedy Jr., the nation’s health secretary, pledged on Thursday to seek out experts globally to discover the reasons for the increasing rates of autism in the United States.“We’ve launched a massive testing and research effort that’s going to involve hundreds of scientists from around the world,” Mr. Kennedy announced at a cabinet meeting held by President Trump. “By September, we will know what has caused the autism epidemic and we’ll be able to eliminate those exposures.”“There will be no bigger news conference than that,” Mr. Trump replied.But scientists who have worked for decades to find a cause greeted Mr. Kennedy’s predicted timeline with skepticism.They said that a single answer would be hard to identify in a field of possible contributors including pesticides, air pollution and maternal diabetes.Dr. Philip Landrigan, a pediatrician and expert on environmental toxins, pointed to the current mass layoffs and cutbacks for research at Mr. Kennedy’s Department of Health and Human Services as one reason for doubting such quick progress.“Given that a great deal of research on autism and other pediatric diseases in hospitals and medical schools is currently coming to a halt because of federal funding cuts from H.H.S.,” he said, “it is very difficult for me to imagine what profound scientific breakthrough could be achieved between now and September.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More